A pilot prospective safety trial of delivering anticoagulation therapy in children at risk of thrombocytopenia

Dr. Felipe Fajardo, PGY2

Supervisor: Dr. Mihir Bhatt

There is a lack of evidence surrounding the delivery of anticoagulant therapy (ACT) in the context of concurrent thrombocytopenia. This study is a prospective pilot study that will investigate the safety of delivering anticoagulant therapy (ACT) according to our institutional protocol for patients with a thromboembolism who are at risk for thrombocytopenia. This will provide further evidence for the safety of this protocol in assessing any major or clinically relevant non-major bleeds.

Objectives:

  • To review the literature surrounding anti coagulation therapy and thrombocytopenia
  • To discuss our plans for the prospective study assessing the safety of our institutional protocol regarding ACT and thrombocytopenia

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s